Stocks · Health care · Pharmaceutical Preparations

Indivior Pharmaceuticals, Inc.

INDV Clue Score71
United States Fiscal year ends December CIK 0001625297 Results filed 29 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Christian Heidbreder
10 Jul 2026
Chief Scientific Officer
Sold on a plan
18,586
$41.14
$764.63K
Christian Heidbreder
11 Jun 2026
Chief Scientific Officer
Sold on a plan
18,586
$38.06
$707.38K
Ryan Preblick
8 Jun 2026
Chief Financial Officer
Sold on a plan
36,000
$37.70
$1.36M

What was left out

Form 4 filings counted 48
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 6,248,367
History held since 7 Jan 2026